|
|
10 East 53rd Street
New York, NY 10022 USA
phone:(212) 755-5461
fax:(212) 983-2379
|
|
| Symbol |
PGNT |
| Exchange |
.OB |
| Founded |
0 |
| Employees |
1 |
|
|
|
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Currently seeking new business opportunities. |
|
| Management |
| Salvatore Bucci, President and CEO |
| |
|
|
|
|
|
|
|
| Keywords |
| hiv, std, cancer, HIVAIDS |
|
|
|
| Description |
|
Paligent Inc. is engaged in seeking business opportunities. It has evaluated various strategic alternatives, including acquisitions of new operating businesses and technologies, as well as potential merger opportunities. |
|
| Products / Services |
Outliscensed: PRO 2000 Gel is a topical microbicide designed to prevent the sexual transmission of Human Immunodeficiency Virus (HIV) and other sexually transmitted disease pathogens. Development activities are being conducted by Indevus Pharmaceuticals, Inc. (Indevus).
O6-BG is a deoxyribonucleic acid (DNA) repair protein inhibitor, a chemosensitizer that is designed to overcome resistance to a class of commonly used chemotherapeutic agents, known as O6-alkylating agents. O6-BG and related compounds are small molecules for intravenous administration in the treatment of cancer. The development activities are being conducted by AOI Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
